Biphasic modulation by nitric oxide of caspase activation due to malonate injection in rat striatum

European Journal of Pharmacology

Volumn 483, Issue 2-3, 2004, Pages 259-265

  Paucard, Alexia ^a   Palmier, Bruno ^a   Croci, Nicole ^a   Taillieu, Fanny ^a   Plotkine, Michel ^a   Margaill, Isabelle ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

7 Nitroindazole; Caspase; Malonate; Nitric oxide (NO); Oxidative stress

Indexed keywords

7 NITROINDAZOLE; CASPASE 3; MALONIC ACID; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EVALUATION; EXPERIMENTAL MODEL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0346056868     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.10.038     Document Type: Article

References (53)

1. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:2001;593-615.
2. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
3. Beal M.F., Brouillet E., Jenkins B., Henshaw R., Rosen B., Hyman B.T. Age dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61:1993;1147-1150.
4. Benchoua A., Guegan C., Couriaud C., Hosseini H., Sampaio N., Morin D., Onteniente B. Specific caspase pathways are activated in the two stages of cerebral infarction. J. Neurosci. 21:2001;7127-7134.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Brockhaus F., Brune B. p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide. Oncogene. 18:1999;6403-6410.
7. Brune B., von Knethen A., Sandau K.B. Nitric oxide and its role in apoptosis. Eur. J. Pharmacol. 351:1998;261-272.
8. Connop B.P., Rolfe N.G., Boegman R.J., Jhamandas K., Beninger R.J. Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole. Neuropharmacology. 33:1994;1439-1445.
9. Davoli M.A., Fourtounis J., Tam J., Xanthoudakis S., Nicholson D., Robertson G.S., Ng G.Y., Xu D. Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat. Neuroscience. 115:2002;125-136.
10. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 88:1991;6368-6371.
11. Demougeot C., Garnier P., Mossiat C., Bertrand N., Giroud M., Beley A., Marie C. N Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J. Neurochem. 77:2001;408-415.
12. Elibol B., Soylemezoglu F., Unal I., Fujii M., Hirt L., Huang P.L., Moskowitz M.A., Dalkara T. Nitric oxide is involved in ischemia-induced apoptosis in brain: a study in neuronal nitric oxide synthase null mice. Neuroscience. 105:2001;79-86.
13. Espoti M.D. The roles of Bid. Apoptosis. 7:2002;433-440.
14. Fink K., Zhu J., Namura S., Shimizu-Sasamata M., Endres M., Ma J., Dalkara T., Yuan J., Moskowitz M.A. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. 18:1998;1071-1076.
15. Fujimura M., Morita-Fujimura Y., Noshita N., Sugawara T., Kawase M., Chan P.H. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J. Neurosci. 20:2000;2817-2824.
16. Golanov E.V., Reis D.J. Contribution of cerebral edema to the neuronal salvage elicited by stimulation of cerebral fastiglial nucleus after occlusion of the middle cerebral artery in rat. J. Cereb. Blood Flow Metab. 15:1995;172-174.
17. Grandati M., Verrecchia C., Revaud M.L., Allix M., Boulu R.G., Plotkine M. Calcium-independent NO-synthase activity and nitrites/nitrates production in transient focal cerebral ischaemia in mice. Br. J. Pharmacol. 122:1997;625-630.
18. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
19. Greene J.G., Greenamyre J.T. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. 64:1995;430-436.
20. Greene J.G., Porter R.H., Eller R.V., Greenamyre J.T. Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61:1993;1151-1154.
21. Henshaw R., Jenkins B.G., Schulz J.B., Ferrante R.J., Kowall N.W., Rosen B.R., Beal M.F. Malonate produces striatal lesions by indirect NMDA receptor activation. Brain Res. 647:1994;161-166.
22. Kaufmann S.H., Hengartner M.O. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 11:2001;526-534.
23. Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272:1997;31138-31148.
24. Kim Y.M., Bombeck C.A., Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. 84:1999;253-256.
25. Kim P.K., Zamora R., Petrosko P., Billiar T.R. The regulatory role of nitric oxide in apoptosis. Int. Immunopharmacol. 1:2001;1421-1441.
26. Kim P.K., Kwon Y.G., Chung H.T., Kim Y.M. Regulation of caspases by nitric oxide. Ann. N. Y. Acad. Sci. 962:2002;42-52.
27. Köhler C., Orrenius S., Zhivotovsky B. Evaluation of caspase activity in apoptotic cells. J. Immunol. Methods. 265:2002;97-110.
28. Le D.A., Wu Y., Huang Z., Matsushita K., Plesnila N., Augustinack J.C., Hyman B.T., Yuan J., Kuida K., Flavell R.A., Moskowitz M.A. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl. Acad. Sci. U. S. A. 99:2002;15188-15193.
29. Leist M., Volbracht C., Kuhnle S., Fava E., Ferrando-May E., Nicotera P. Caspase mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol. Med. 3:1997;750-764.
30. Li J., Billiar T.R., Talanian R.V., Kim Y.M. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun. 240:1997;419-424.
31. Li H., Colbourne F., Sun P., Zhao Z., Buchan A.M., Iadecola C. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke. 31:2000;176-182.
32. Love S., Barber R., Wilcock G.K. Neuronal death in brain infarcts in man. Neuropathol. Appl. Neurobiol. 26:2000;55-66.
33. MacKenzie G.M., Rose S., Bland-Ward P.A., Moore P.K., Jenner P., Marsden C.D. Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. NeuroReport. 5:1994;1993-1996.
34. Maiese K., Vincent A.M. Group I metabotropic receptors down-regulate nitric oxide induced caspase-3 activity in rat hippocampal neurons. Neurosci. Lett. 264:1999;17-20.
35. Mattson M.P., Duan W., Pedersen W.A., Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis. 6:2001;69-81.
36. Messam C.A., Greene J.G., Greenamyre J.T., Robinson M.B. Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801. Brain Res. 684:1995;221-224.
37. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
38. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993;219-224.
39. Morita-Fujimura Y., Fujimura M., Yoshimoto T., Chan P.H. Superoxide during reperfusion contributes to caspase-8 expression and apoptosis after transient focal stroke. Stroke. 32:2001;2356-2361.
40. Nicotera P., Leist M., Fava E., Berliocchi L., Volbracht C. Energy requirement for caspase activation and neuronal cell death. Brain Pathol. 10:2000;276-282.
41. Radi R., Cassina A., Hodara R., Quijano C., Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 33:2002;1451-1464.
42. Sartorius U., Schmitz I., Krammer P.H. Molecular mechanisms of death-receptor-mediated apoptosis. ChemBioChem. 2:2001;20-29.
43. Sastry P.S., Rao K.S. Apoptosis and the nervous system. J. Neurochem. 74:2000;1-20.
44. Schulz J.B., Matthews R.T., Jenkins B.G., Ferrante R.J., Siwek D., Henshaw D.R., Cipolloni P.B., Mecocci P., Kowall N.W., Rosen B.R., Beal M.F. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15:1995;8419-8429.
45. Schulz J.B., Matthews R.T., Muqit M.M., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
46. Schulz J.B., Huang P.L., Matthews R.T., Passov D., Fishman M.C., Beal M.F. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67:1996;430-433.
47. Schulz J.B., Weller M., Matthews R.T., Heneka M.T., Groscurth P., Martinou J.C., Lommatzsch J., von Coelln R., Wullner U., Loschmann P.A., Beal M.F., Dichgans J., Klockgether T. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ. 5:1998;847-857.
48. Schulz J.B., Weller M., Moskowitz M.A. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann. Neurol. 45:1999;421-429.
49. Talanian R.V., Quinlan C., Trautz S., Hackett M.C., Mankovich J.A., Banach D., Ghayur T., Brady K.D., Wong W.W. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:1997;9677-9682.
50. Tamatani M., Ogawa S., Nunez G., Tohyama M. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Cell Death Differ. 5:1998;911-919.
51. Troy C.M., Salvesen G.S. Caspases on the brain. J. Neurosci. Res. 69:2002;145-150.
52. Yoshida T., Limmroth V., Irikura K., Moskowitz M.A. The NOS inhibitor, 7 nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood Flow Metab. 14:1994;924-929.
53. Zimmermann K.C., Bonzon C., Green D.R. The machinery of programmed cell death. Pharmacol. Ther. 92:2001;57-70.